Allergen Immunotherapy: Vaccine Modification.
Immunol Allergy Clin North Am
; 36(1): 103-24, 2016 Feb.
Article
en En
| MEDLINE
| ID: mdl-26617230
ABSTRACT
There is a need for newer therapeutic agents that improve the safety of allergen immunotherapy, provide ease of delivery to patients that fosters compliance and allows access to a greater proportion of the allergic population who could benefit from this disease-modifying treatment, and achieve an acceptable therapeutic benefit for patients committing to the treatment. The advances in sublingual allergen immunotherapy are encouraging, as this offers patients a noninjectable form of treatment of inhalant allergies. The continued research and development of the novel therapeutic constructs discussed in this article holds the promise of accomplishing the aforementioned goals in the future.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Fragmentos de Péptidos
/
Alérgenos
/
Vacunas
/
Desensibilización Inmunológica
/
Hipersensibilidad
/
Mastocitos
Límite:
Animals
/
Humans
Idioma:
En
Revista:
Immunol Allergy Clin North Am
Asunto de la revista:
ALERGIA E IMUNOLOGIA
Año:
2016
Tipo del documento:
Article